Core Viewpoint - Fuman Microelectronics (300671.SZ) reported a revenue of 592 million yuan for the first three quarters, marking a year-on-year increase of 19.32%, despite a net loss of 59 million yuan, which represents an 8.24% decline compared to the previous year [1][3] Financial Performance - The company achieved an operating income of 592 million yuan, reflecting a 19.32% year-on-year growth [1] - The net profit attributable to shareholders was -59 million yuan, showing an 8.24% decrease year-on-year [1] - Basic earnings per share were -0.27 yuan, which is a 10.00% increase year-on-year [1] Business Operations - Despite the net loss, the company's main business continues to grow, with revenue scale expanding [3] - During the reporting period, the company optimized its product structure in key areas such as power management chips, analog signal chains, and mixed-signal SoCs, enhancing cost control and supply chain collaboration [3] - Fuman Microelectronics is an integrated circuit design company, with main products including power management chips, LED driver chips, audio amplifiers, and MCU chips, widely used in consumer electronics, lighting, and smart terminals [3] Industry Outlook - Industry experts believe that Fuman Microelectronics' revenue growth amidst the semiconductor industry's recovery lays a foundation for future profit recovery [3] - The gradual mass production of the next generation of high-performance power management chips is expected to improve the company's profitability in upcoming quarters [3]

Core Insights - The company reported a revenue of 592 million yuan for the first three quarters of 2025, representing a year-on-year growth of 19.32% [1] - The net loss attributable to shareholders of the listed company was 59.47 million yuan [1] - The net loss attributable to shareholders after deducting non-recurring gains and losses was 81.12 million yuan [1] - The basic loss per share was 0.27 yuan [1]

Group 1 - Company Fuman Micro reported a revenue of approximately 592 million yuan for the first three quarters of 2025, representing a year-on-year increase of 19.32% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 59.47 million yuan, with a basic earnings per share loss of 0.27 yuan [1] - As of the report date, Fuman Micro's market capitalization was 8 billion yuan [2] Group 2 - The Chinese innovative drug sector has generated 80 billion USD in overseas licensing deals this year [2] - The secondary market for biopharmaceuticals is experiencing a surge, while the primary market is facing challenges in fundraising [2]

Financial Performance - The company's revenue for Q3 2025 was ¥208,773,789.27, representing an increase of 8.19% compared to the same period last year, and a year-to-date revenue of ¥591,566,032.66, up 19.32%[5] - The net profit attributable to shareholders for Q3 2025 was -¥23,699,266.77, a decrease of 39.51% year-on-year, with a year-to-date net profit of -¥59,466,792.28, reflecting an increase in losses of 8.24%[5] - The basic earnings per share for Q3 2025 was -¥0.11, down 37.50% compared to the same period last year, while the diluted earnings per share was -¥0.10, a decrease of 42.86%[5] - Total operating revenue for the current period reached ¥591,566,032.66, an increase of 19.3% compared to ¥495,770,101.99 in the previous period[21] - Net loss for the current period was ¥59,466,792.28, slightly improved from a net loss of ¥64,806,517.98 in the previous period[22] - Basic earnings per share for the current period was -¥0.27, compared to -¥0.30 in the previous period[22] Assets and Liabilities - The total assets at the end of Q3 2025 were ¥2,468,233,754.87, a decrease of 6.43% from the end of the previous year[5] - Total assets decreased to ¥2,468,233,754.87 from ¥2,637,844,177.86, reflecting a decline of 6.4%[19] - Total liabilities decreased to ¥899,275,574.76 from ¥1,009,233,425.71, a reduction of 10.9%[19] - Total current assets decreased from ¥1,459,025,411.18 to ¥1,266,051,065.22, a reduction of about 13.2%[17] - Long-term receivables decreased from ¥6,623,963.79 to ¥3,842,028.41, a decline of about 42.4%[17] - Non-current assets totaled ¥1,202,182,689.65, slightly up from ¥1,178,818,766.68, indicating a growth of 2.0%[19] Cash Flow - The cash flow from operating activities for Q3 2025 was -¥103,078,002.12, a significant decline of 222.46% compared to the previous year[9] - Operating cash flow for the current period was -¥103,078,002.12, a decrease from ¥84,176,059.20 in the previous period[23] - Total cash outflow from operating activities was ¥555,339,407.97, compared to ¥417,234,241.58 in the prior period[23] - Cash inflow from investment activities increased to ¥1,556,956,815.22, compared to ¥1,159,692,002.15 in the prior period[23] - Net cash flow from investment activities was ¥149,153,615.83, up from ¥63,563,383.37 year-over-year[23] - Cash inflow from financing activities totaled ¥573,515,475.65, compared to ¥534,380,875.67 in the previous period[24] - Net cash flow from financing activities improved to -¥37,693,720.76 from -¥224,624,005.58 year-over-year[24] Shareholder Information - Total number of common stock shareholders at the end of the reporting period is 47,329[11] - The largest shareholder, Jijing (Hong Kong) Limited, holds 31.65% of shares, totaling 68,910,043 shares[11] - The total number of restricted shares at the end of the period is 605,923 shares, with 32,907 shares newly restricted[14] - The company has no preferred shareholders or related changes in preferred stock ownership[12] - There are no significant changes in the top 10 shareholders or their shareholding status due to securities lending[12] Operating Costs and Expenses - The company experienced a 32.25% increase in operating costs, totaling ¥538,165,085.47, due to higher sales revenue[9] - Total operating costs increased to ¥652,890,884.22, up 14.7% from ¥569,333,866.84 in the previous period[21] - Research and development expenses for Q3 2025 amounted to ¥70,614,368.20, a decrease of 36.69% year-on-year, primarily due to costs related to products entering mass production being directly included in operating costs[8] - Research and development expenses were ¥70,614,368.20, down 36.7% from ¥111,531,705.77 in the previous period[21] - The company reported a significant decrease in other income, which fell by 79.36% to ¥6,349,045.12, primarily due to reduced government subsidies received[9] Audit and Compliance - The company did not undergo an audit for the third quarter financial report[25]

Group 1 - The core point of the article highlights the performance and financial metrics of Fuman Microelectronics, which saw a stock price increase of 5.19% to 35.87 CNY per share, with a total market capitalization of 7.81 billion CNY [1] - Fuman Microelectronics specializes in the design, research and development, packaging, testing, and sales of high-performance analog and mixed-signal integrated circuits, with revenue breakdowns showing that power management chips account for 38.51%, LED-related chips for 32.16%, MOSFET chips for 14.56%, and other chips for 14.55% [1] - The company is located in Shenzhen, Guangdong Province, and was established on November 5, 2001, with its listing date on July 5, 2017 [1] Group 2 - From the perspective of fund holdings, the Everbright Prudential Fund has a significant position in Fuman Microelectronics, with the Everbright Prudential Hengxin Mixed A Fund reducing its holdings by 500 shares to 6,000 shares, representing 1.63% of the fund's net value [2] - The Everbright Prudential Hengxin Mixed A Fund was established on November 30, 2021, and has a current scale of 6.90 million CNY, with a year-to-date return of 14.07% and a one-year return of 16.3% [2] - The fund manager, Hua Yeshun, has been in position for 3 years and 35 days, overseeing a total asset scale of 12.4 million CNY, with the best and worst fund returns during his tenure being 19.13% and 9.38%, respectively [3]

Core Points - The stock price of Fuman Micro fell by 2.04% on October 14, closing at 37.06 CNY per share with a trading volume of 1.23 billion CNY and a turnover rate of 1.50% [1] - The company has seen a year-to-date stock price increase of 4.28%, with a decline of 3.74% over the last five trading days and a 0.19% decrease over the last 20 days, while experiencing a 17.99% increase over the last 60 days [1] - Fuman Micro's main business includes the design, research and development, packaging, testing, and sales of high-performance analog and mixed-signal integrated circuits, with revenue contributions from power management chips (38.51%), LED-related chips (32.16%), MOSFET chips (14.56%), and others [2] - As of June 30, 2025, Fuman Micro reported a revenue of 383 million CNY, representing a year-on-year growth of 26.42%, while the net profit attributable to the parent company was -35.77 million CNY, showing a year-on-year increase of 25.20% [2] Financial Performance - Fuman Micro has cumulatively distributed dividends of 96.54 million CNY since its A-share listing, with no dividends distributed in the last three years [3] - As of June 30, 2025, the number of shareholders increased by 3.52% to 42,300, while the average circulating shares per person decreased by 3.40% to 5,133 shares [2]

Group 1 - The company held its fourth board meeting on September 29, 2025, to discuss various proposals, including the completion of fundraising projects and the allocation of remaining funds to supplement working capital [1] - The meeting was conducted both in-person and via telecommunication, indicating a flexible approach to governance [1] Group 2 - The announcement reflects the company's ongoing commitment to managing its financial resources effectively [1] - The decision to permanently allocate remaining funds to working capital suggests a strategic focus on enhancing liquidity [1]

Core Points - The company announced the completion of a fundraising project related to the production of 5G RF chips, LED chips, and power management chips, which has reached the intended usable state [1] - The total investment for the project was 566.53 million yuan, with actual funds used amounting to 503.39 million yuan, leaving a remaining balance of 10.73 million yuan, including interest income and cash management returns [1] - The remaining funds will be permanently allocated to supplement working capital for daily operations and business development, and this decision does not require shareholder meeting approval [1]

中信证券股份有限公司 关于富满微电子集团股份有限公司 募投项目结项并将该项目剩余募集资金永久补充流动资金 的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐人"）作为富满微电子集团 股份有限公司（以下简称"富满微"、"公司"）2021 年度向特定对象发行股票的保荐人， 根据《证券发行上市保荐业务管理办法》《上市公司募集资金监管规则》《深圳证券交易 所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第13号——保荐业务》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等有关 规定，对富满微募投项目结项并将该项目剩余募集资金永久补充流动资金的核查意见事 项进行了核查，核查情况如下： 一、募集资金基本情况 经中国证券监督管理委员会出具的《关于同意富满微电子集团股份有限公司向特定 对象发行股票注册的批复》（证监许可﹝2021﹞3406 号）核准，公司本次向特定对象发 行 A 股股票 11,732,499 股，募集资金总额 899,999,998.29 元，扣除各项发行费用（不含 增值税）人民币 9,803,521.23 元，公司募集资金净额为 890,196,477.0 ...

证券代码：300671 证券简称：富满微 公告编号：2025-031 富满微电子集团股份有限公司 关于募投项目结项并将该项目剩余募集资金永久补充流动 资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 富满微电子集团股份有限公司（以下简称"公司"）于2025年9月29日召开 了第四届董事会第十二次会议，审议通过了《关于募投项目结项并将该项目剩 余募集资金永久补充流动资金的议案》，同意公司5G射频芯片、LED芯片及电源 管理芯片生产项目结项，并将该项目剩余募集资金永久补充流动资金，用于公 司日常生产经营及业务发展，该事项无需提交公司股东会审议。 现将具体内容公告如下： 一、募集资金基本情况 经中国证券监督管理委员会出具的《关于同意富满微电子集团股份有限公 司向特定对象发行股票注册的批复》（证监许可﹝2021﹞3406号）核准，公司 本次向特定对象发行A股股票11,732,499股，募集资金总额899,999,998.29元， 扣除各项发行费用（不含增值税）人民币9,803,521.23元，公司募集资金净额 为890 ...